![Rupert Vessey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rupert Vessey
Directeur/Bestuurslid bij
BIO-TECHNE CORPORATION
Vermogen: 567 808 $ op 31-05-2026
Profiel
Rupert J. Vessey bekleedt de functie van Executive VP-Research & Early Development bij Bristol Myers Squibb Co. Hij is ook lid van de raad van bestuur van Bio-Techne Corp., PharmAkea, Inc., Sidecar Therapeutics, Inc. en Elstar Therapeutics, Inc. en lid van The Royal College of Physicians. In het verleden bekleedde Rupert J. Vessey de functie van Senior VP-Early Development & Discovery Sciences bij Merck & Co, Inc. en President-Research & Early Development bij Celgene Corp. Dr. Vessey is afgestudeerd, gepromoveerd en gepromoveerd aan de Universiteit van Oxford.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-10-2025 | 10.987 ( 0,01% ) | 567 808 $ | 31-05-2026 | |
| 27-02-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Rupert Vessey
| Bedrijven | Functie | Begin |
|---|---|---|
| BIO-TECHNE CORPORATION | Directeur/Bestuurslid | 26-06-2019 |
| GENERATE BIOMEDICINES, INC. | Directeur/Bestuurslid | 01-06-2024 |
PharmAkea, Inc.
 PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drug candidates against protein targets involved in fibroproliferative diseases | Directeur/Bestuurslid | - |
Sidecar Therapeutics, Inc.
 Sidecar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Bestuurslid | - |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Directeur/Bestuurslid | 01-08-2018 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Nereid Therapeutics, Inc.
 Nereid Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio-molecular condensate drug discovery and development company | Directeur/Bestuurslid | 25-10-2021 |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01-07-2023 |
Eerdere bekende functies van Rupert Vessey
| Bedrijven | Functie | Einde |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Hoofd Techniek/Wetenschap/O&O | 03-07-2023 |
| ░░░░░░░ | ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | - |
Opleiding van Rupert Vessey
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
57
Eerstegraads connecties
14
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 14 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Bio-Techne Corp.
 Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
PharmAkea, Inc.
PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drug candidates against protein targets involved in fibroproliferative diseases | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Sidecar Therapeutics, Inc.
Sidecar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Health Technology |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio-molecular condensate drug discovery and development company | Health Technology |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
